On the occasion of National Cancer Awareness Day, Hyundai Motor India Foundation (HMIF) — the CSR arm of Hyundai Motor India Limited…

On the occasion of National Cancer Awareness Day, Hyundai Motor India Foundation (HMIF) — the CSR arm of Hyundai Motor India Limited (HMIL) — has reaffirmed its commitment to advancing cancer research and treatment through its flagship initiative, ‘Hyundai Hope for Cancer’, developed in collaboration with the Indian Institute of Technology Madras (IIT Madras).

Since its launch in September 2025, the initiative has made remarkable progress in cancer prevention, screening, and genomic research, benefiting thousands across India.

At the core of this program lies the Hyundai Centre for Cancer Genomics at IIT Madras, which houses India’s first community-based Cancer Tissue Biobank and the newly launched Bharat Cancer Genome Atlas (BCGA) — the nation’s first open-access cancer genome database aimed at revolutionizing personalized oncology.

Highlighting Hyundai’s vision for equitable healthcare, Mr. Puneet Anand, AVP & Vertical Head – Corporate Affairs, Corporate Communication & Social, HMIL, said :- Hyundai Hope for Cancer reflects our firm belief that technology, compassion, and collaboration can drive transformative change in cancer care. On National Cancer Awareness Day, we renew our commitment to ensuring timely, personalized, and dignified cancer care for all. With an investment of INR 56 Crore, including a dedicated INR 3 Crore Cancer Care Fund, HMIF is working to build access to early detection, research, and treatment — efforts that have already impacted over 11,000 lives.

Achievements of Hyundai Hope for Cancer :- Community Outreach & Screening :- 109 cancer awareness and screening camps conducted across Tamil Nadu, reaching over 11,000 individuals. Screenings included oral, cervical, colon, breast, and prostate cancers. 448 individuals tested positive and were referred to government hospitals for advanced treatment.

Cancer Tissue Biobank & Genomic Sequencing :- 1,104 cancer tissue samples collected. Whole genome sequencing completed for 528 pediatric leukemia cases. The BCGA launched as India’s first open-access cancer genome database, hosted by IIT Madras. Ongoing genomic studies aim to identify India-specific biomarkers for early diagnosis.

HPV Vaccination Drive :- 525 girls vaccinated against Human Papillomavirus (HPV) in collaboration with Karkinos Healthcare and Cancer Research and Relief Trust (CRRT) across Ariyalur, Virudhunagar, and Salem districts in Tamil Nadu.

Upcoming Initiatives :- Free cancer treatment for underprivileged children in partnership with leading hospitals nationwide. Technician training program to upskill 100+ lab professionals in genomic sequencing and molecular oncology by FY 2026. A fully equipped Cancer Screening Vehicle has already covered 17 districts in Tamil Nadu, with expansion to Maharashtra and Haryana planned next year. Over the next four years, the initiative aims to conduct 225+ awareness and screening camps across Tamil Nadu, Haryana, and Maharashtra, reaching 1.27 lakh people and vaccinating 5,000+ girls against HPV.